SRL
IMVT icon

Scientech Research LLC’s Immunovant IMVT Stock Holding History

Scientech Research LLC’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,691
Closed -$590K – 707
2024
Q3 		$590K Buy
20,691
+8,057
+64% +$238K 0.12% 338
2024
Q2 		$334K Buy
+12,634
New +$359K 0.07% 435

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Scientech Research LLC's IMVT Position: Q4 2024 in Review

Scientech Research LLC sold out of Immunovant (IMVT) in Q4 2024, closing a stake of 20,691 shares — an estimated $590K sold.

Scientech Research LLC first reported a position in IMVT in Q2 2024 and held it in 2 quarters. The position peaked at $590K in Q3 2024. 186 funds tracked by Wall St. Rank hold IMVT as of Q4 2024.

  • Scientech Research LLC reported no remaining Immunovant position as of Q4 2024 after selling out during the quarter.
  • Scientech Research LLC sold 20,691 Immunovant shares in Q4 2024, an estimated $590K.
  • Scientech Research LLC first reported a position in Immunovant in Q2 2024 and held it in 2 quarters.
  • Scientech Research LLC's Immunovant position peaked at $590K in Q3 2024.
  • 186 funds tracked by Wall St. Rank held Immunovant as of Q4 2024.

Based on Scientech Research LLC's 13F filing for Q4 2024, filed 14 Feb 2025.